Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression

被引:18
|
作者
Li, Yunkuo [1 ]
Pan, Yujie [1 ]
Zhao, Xiaodong [1 ]
Wu, Shouwang [1 ]
Li, Faping [1 ]
Wang, Yuxiong [1 ]
Liu, Bin [1 ]
Zhang, Yanghe [2 ]
Gao, Xin [1 ]
Wang, Yishu [2 ]
Zhou, Honglan [1 ]
机构
[1] First Hosp Jilin Univ, Dept Urol, Changchun 130021, Peoples R China
[2] Jilin Univ, Key Lab Pathobiol, Minist Educ, Changchun 130021, Peoples R China
基金
中国国家自然科学基金;
关键词
PPAR; Cancer; Metabolic reprogramming; Anticancer therapy; UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA; PPAR-ALPHA AGONIST; INSULIN-RESISTANCE; ADIPOSE-TISSUE; GAMMA ACTIVATION; GENE-EXPRESSION; HEPATOMA-CELLS; PROFILING REVEALS; BREAST-CANCER; C666-1; CELLS;
D O I
10.1016/j.clnu.2023.12.005
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Lipids represent the essential components of membranes, serve as fuels for high-energy processes, and play crucial roles in signaling and cellular function. One of the key hallmarks of cancer is the reprogramming of metabolic pathways, especially abnormal lipid metabolism. Alterations in lipid uptake, lipid desaturation, de novo lipogenesis, lipid droplets, and fatty acid oxidation in cancer cells all contribute to cell survival in a changing microenvironment by regulating feedforward oncogenic signals, key oncogenic functions, oxidative and other stresses, immune responses, or intercellular communication. Peroxisome proliferator-activated receptors (PPARs) are transcription factors activated by fatty acids and act as core lipid sensors involved in the regulation of lipid homeostasis and cell fate. In addition to regulating whole-body energy homeostasis in physiological states, PPARs play a key role in lipid metabolism in cancer, which is receiving increasing research attention, especially the fundamental molecular mechanisms and cancer therapies targeting PPARs. In this review, we discuss how cancer cells alter metabolic patterns and regulate lipid metabolism to promote their own survival and progression through PPARs. Finally, we discuss potential therapeutic strategies for targeting PPARs in cancer based on recent studies from the last five years.(c) 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:332 / 345
页数:14
相关论文
共 50 条
  • [1] Lipid metabolism: peroxisome proliferator-activated receptors
    van Heyningen, Charles
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (04) : 470 - 472
  • [2] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS AND LIPID-METABOLISM
    KELLER, H
    MAHFOUDI, A
    DREYER, C
    HIHI, AK
    MEDIN, J
    OZATO, K
    WAHLI, W
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1993, 684 : 157 - 173
  • [3] Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer
    Wang, Dingzhi
    DuBois, Raymond N.
    PPAR RESEARCH, 2008, 2008
  • [4] Peroxisome proliferator-activated receptors and the regulation of mammalian lipid metabolism
    Smith, SA
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 : 1086 - 1090
  • [5] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS - A LINK BETWEEN ENDOCRINOLOGY AND NUTRITION
    KELLER, H
    WAHLI, W
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1993, 4 (09): : 291 - 296
  • [6] Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
    Chinetti, G
    Fruchart, JC
    Staels, B
    INFLAMMATION RESEARCH, 2000, 49 (10) : 497 - 505
  • [7] Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth
    Asgharzadeh, Fereshteh
    Memarzia, Arghavan
    Alikhani, Vida
    Beigoli, Sima
    Boskabady, Mohammad Hossein
    TRANSLATIONAL ONCOLOGY, 2024, 47
  • [8] Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
    G. Chinetti
    J.-C. Fruchart
    B. Staels
    Inflammation Research, 2000, 49 : 497 - 505
  • [9] Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis
    Barbier, O
    Torra, IP
    Duguay, Y
    Blanquart, C
    Fruchart, JC
    Glineur, C
    Staels, B
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : 717 - 726
  • [10] Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors
    Lee, CH
    Olson, P
    Evans, RM
    ENDOCRINOLOGY, 2003, 144 (06) : 2201 - 2207